NanoVelos Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.12M
- Investors
-
7
NanoVelos General Information
Description
Developer of cancer treatment drugs designed to create a method of coating active substances with nano-particles of polysaccharides. The company's technology transforms generics to super-generics via a dextran-based nano-particle delivery system and exhibits dramatically improved tumor targeting, enabling medical professionals to enhance therapeutic efficacy while minimizing adverse effects on healthy tissues.
Contact Information
Website
www.nanovelos.comCorporate Office
- Rakowiecka 36
- Room 260
- Warsaw, 02-532
- Poland
Corporate Office
- Rakowiecka 36
- Room 260
- Warsaw, 02-532
- Poland
NanoVelos Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC | 16-Dec-2017 | $1.12M | Completed | Generating Revenue | ||
3. Early Stage VC | 01-Jul-2015 | Completed | Generating Revenue | |||
2. Grant | $347K | Completed | Startup | |||
1. Early Stage VC | 10-Apr-2013 | Completed | Startup |
NanoVelos Patents
NanoVelos Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3761955-A1 | Anthracycline encapsulated with polysaccharide for use in the treatment of tumours | Pending | 06-Mar-2018 | ||
US-20210052616-A1 | Anthracycline encapsulated with a polysaccharide for use in the treatment of tumours | Inactive | 06-Mar-2018 | ||
ES-2780387-T3 | Procedure for the preparation of polysaccharide nanoparticles | Active | 14-Mar-2012 | ||
CA-2866682-A1 | Process for the preparation of polysaccharide nanoparticles | Active | 14-Mar-2012 | ||
US-10258579-B2 | Process for the preparation of polysaccharide nanoparticles | Active | 14-Mar-2012 | C08B1/12 |
NanoVelos Signals
NanoVelos Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
ZernikeMeta Ventures | Venture Capital | Minority | ||
Angel (individual) | Minority | |||
PFR Ventures | Limited Partner | Minority | ||
Giza Polish Ventures | Venture Capital | Minority | ||
Krajowy Fundusz Kapitałowy | Fund of Funds | Minority |
NanoVelos FAQs
-
When was NanoVelos founded?
NanoVelos was founded in 2013.
-
Where is NanoVelos headquartered?
NanoVelos is headquartered in Warsaw, Poland.
-
What is the size of NanoVelos?
NanoVelos has 4 total employees.
-
What industry is NanoVelos in?
NanoVelos’s primary industry is Drug Delivery.
-
Is NanoVelos a private or public company?
NanoVelos is a Private company.
-
What is the current valuation of NanoVelos?
The current valuation of NanoVelos is
. -
What is NanoVelos’s current revenue?
The current revenue for NanoVelos is
. -
How much funding has NanoVelos raised over time?
NanoVelos has raised $1.12M.
-
Who are NanoVelos’s investors?
ZernikeMeta Ventures, , PFR Ventures, Giza Polish Ventures, and Krajowy Fundusz Kapitałowy are 5 of 7 investors who have invested in NanoVelos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »